⚠ SAFETY NOTICE
If you or someone you love is in immediate danger, call 911.
If you’re having thoughts of suicide or are in emotional crisis, call or text 988 to reach the Suicide & Crisis Lifeline.
The Mental Health Hotline offers support and resources and is not a substitute for emergency services.
QUICK ANSWER
PMDD, premenstrual dysphoric disorder, is more than severe PMS. It’s a depressive disorder in the DSM-5-TR with specific symptom, timing and impairment criteria. At least five significant symptoms appear during the luteal phase, after ovulation and before your period, then improve after menstruation begins. Diagnosis requires tracking symptoms daily across at least two cycles. PMDD is treatable, and SSRIs can work more quickly for PMDD than they typically do for depression.
If your mood drops on a predictable schedule and then improves when your period arrives, there may be a reason for the pattern. PMDD affects roughly 1% to 5% of people who menstruate, depending on how strictly it’s diagnosed, and it can be mistaken for severe PMS.
That distinction matters. PMDD is classified in the DSM-5-TR as a depressive disorder with specific diagnostic criteria and evidence-based treatment options. Recognizing the pattern can help you have a more informed conversation with a health care provider about appropriate care.
What Is Premenstrual Dysphoric Disorder?
PMDD is a cyclical depressive disorder tied to the menstrual cycle. Symptoms develop during the luteal phase, the time after ovulation and before menstruation, then improve within a few days after your period starts. By the week after your period, symptoms are typically minimal or absent. This pattern of remission is an important diagnostic feature that helps distinguish PMDD from other conditions with similar symptoms.
It’s Not Caused by Abnormal Hormone Levels
Some people are told their bloodwork is normal and conclude that nothing is wrong. Current understanding is that PMDD involves an unusual sensitivity to normal hormonal fluctuations rather than abnormal hormone levels. Progesterone metabolites, particularly allopregnanolone, affect GABA signaling and serotonin systems, and the brain appears to respond differently to these normal shifts in people with PMDD. Normal hormone levels don’t rule out the condition.
PMDD Symptoms
A DSM-5-TR diagnosis requires at least five symptoms during most cycles in the past year, with at least one from the core mood group.
Core Mood Symptoms (At Least One Required)
- Marked mood swings. This may include sudden tearfulness or heightened sensitivity to rejection.
- Marked irritability or anger. You may notice more conflict with the people around you.
- Markedly depressed mood. This can include hopelessness or harsh self-criticism.
- Marked anxiety or tension. You may feel keyed up or on edge.
Additional Symptoms
Other symptoms can include reduced interest in usual activities, difficulty concentrating, fatigue or low energy, changes in appetite or specific food cravings, sleeping too much or too little, a sense of being overwhelmed or out of control and physical symptoms such as breast tenderness, bloating, joint or muscle pain and headaches.
Persistent crying spells and mood swings that appear on a predictable schedule can also be part of the pattern.
Cyclical Suicidal Thoughts Are a Recognized Feature
Suicidal thinking that appears during the luteal phase and eases with menstruation is a documented feature of PMDD. If this pattern sounds familiar, it deserves prompt attention and support.
In one study of 110 women with prospectively assessed and diagnosed PMDD, 39.1% reported current suicidal ideation during the late luteal phase. Rates of lifetime suicidal thoughts, planning and attempts are also higher in PMDD populations than in the general population. In 2024, an article in The Lancet Psychiatry proposed considering suicidality for inclusion in the formal diagnostic criteria.
Any suicidal thinking warrants immediate attention. Treating PMDD may help address symptoms that contribute to these thoughts, but don’t wait for the next phase of your cycle to seek support. If you’re having thoughts of suicide, call or text 988 to reach the 988 Suicide & Crisis Lifeline, no matter where you are in your cycle. Tell the clinician about the timing pattern too, since that information can help with assessment and treatment planning.
PMDD vs. PMS, Premenstrual Exacerbation and Depression
These conditions can look similar, but the timing and severity of symptoms help distinguish them. One of the most useful questions is what happens after your period ends.
| Condition | Timing Pattern | Severity | What It Means for Treatment |
|---|---|---|---|
| PMDD | Symptoms occur during the luteal phase, then improve substantially after menstruation begins. | At least five symptoms, including one from the core mood group, with significant impairment. | SSRIs can work quickly, so luteal-phase-only dosing may be an option. |
| PMS | Symptoms follow a similar luteal-phase pattern and improve after menstruation begins. | Symptoms are generally milder than PMDD and don’t meet PMDD diagnostic criteria. | Lifestyle measures, NSAIDs and sometimes calcium may help. |
| Premenstrual exacerbation (PME) | Symptoms worsen before your period but don’t fully go away afterward. | The underlying condition is present throughout the month. | Treatment focuses on the underlying condition. Luteal-phase-only dosing may not be appropriate. |
| Major depression | Symptoms are persistent rather than limited to a specific phase of the menstrual cycle. | Depressed mood or other symptoms continue beyond the premenstrual window. | Treatment may include continuous antidepressant medication, therapy or both. |
PME can be easy to miss because symptoms become more intense before a period but don’t fully resolve afterward. In one recent study of women with depression, 54.3% had lower average mood ratings around menstruation than during the rest of their cycle, a pattern consistent with premenstrual exacerbation. PME can also occur alongside bipolar disorder, PTSD, eating disorders and borderline personality disorder.
If your symptoms never fully clear after your period starts, a clinician can help determine whether PME or another condition better explains the pattern.
Other Conditions Worth Ruling Out
Depression and anxiety disorders are usually present beyond the premenstrual window, though depression symptoms in women may sometimes be attributed to the menstrual cycle when they aren’t actually cycle-linked. Bipolar disorder also involves mood episodes that aren’t usually limited to one phase of the menstrual cycle, though symptoms may worsen premenstrually.
Thyroid conditions can cause mood changes, fatigue and other overlapping symptoms and may be evaluated with blood testing. Perimenopause can also affect mood and sleep and may occur alongside PMDD.
How PMDD Is Diagnosed
There isn’t a blood test for PMDD. Diagnosis relies on prospective daily symptom tracking across two consecutive menstrual cycles. This helps confirm whether symptoms follow the timing pattern required for PMDD rather than relying only on memory of previous cycles.
What to do:
- Track symptoms daily. Record both difficult days and days when symptoms improve so the pattern is clear.
- Use a standard instrument if you can. The Daily Record of Severity of Problems (DRSP) is commonly used to track PMDD symptoms.
- Log two full cycles. Tracking across two cycles is part of confirming the diagnosis.
- Note the timing of your worst days. Record when symptoms become more intense and when they begin to ease.
- Bring your record to a health care provider. A gynecologist, primary care doctor or mental health professional can review the pattern and help determine the next steps.
If you’ve raised these concerns before and felt dismissed, bringing a daily symptom record may help make the pattern easier to evaluate. If you’re having trouble finding support, you can call the Mental Health Hotline at 866-903-3787 to talk through options in your area.
PMDD Treatment Options
SSRIs and Why the Dosing Is Unusual
SSRIs are a first-line treatment for PMDD. Sertraline, fluoxetine and paroxetine CR have FDA approval for this indication. PMDD treatment can differ from depression treatment in a few important ways:
- Response can be rapid. With PMDD, improvement from SSRIs may appear within days rather than taking several weeks.
- Luteal-phase-only dosing may be an option. Because the response can occur quickly, some people take an SSRI only during the luteal phase, usually the two weeks before their period.
- Serotonergic antidepressants have the strongest evidence. Other antidepressants, including bupropion, haven’t shown the same benefit for PMDD.
Your prescriber can help determine which medication and dosing schedule fit your symptoms. Don’t change when or how you take an antidepressant without medical guidance.
Hormonal Options
Certain combined oral contraceptives containing drospirenone are used to treat PMDD and may help by suppressing ovulation. Hormonal contraception can affect mood differently from person to person. For severe symptoms that don’t respond to other treatments, GnRH agonists may be used to suppress ovarian function, usually with add-back hormone therapy and specialist supervision.
Therapy
Cognitive behavioral therapy (CBT) may help with the effects PMDD has on relationships, work and self-blame. Therapy can be used alongside medication. Recognizing your cycle pattern may also help you prepare for more difficult days.
Lifestyle and Supplements
Regular aerobic exercise and consistent sleep may help support overall well-being. Calcium has also been studied for premenstrual symptoms. Evidence for other supplements, including magnesium and chasteberry, is less clear.
⚠ SUPPLEMENT SAFETY
Vitamin B6 has been studied for premenstrual symptoms. High doses taken over time may increase the risk of nerve damage. Supplements shouldn’t replace medical treatment when symptoms are severe or disabling. Talk with your doctor before starting a supplement, especially if you’re taking an antidepressant or other medication.
Frequently Asked Questions
No. PMS isn’t a psychiatric diagnosis, while PMDD is classified as a depressive disorder in the DSM-5-TR with specific symptom, timing and impairment criteria. The difference isn’t only severity. PMDD includes significant mood symptoms that appear during the luteal phase and improve after menstruation begins, and some treatments used for PMDD aren’t typically used for PMS.
Diagnosis requires prospective daily symptom tracking across at least two menstrual cycles. In practice, the process may take longer if symptoms haven’t been tracked before an appointment. Starting a daily symptom log can help your health care provider see whether your symptoms follow the pattern required for PMDD.
Yes. Cyclical suicidal thinking tied to the luteal phase is a documented feature of PMDD. In one study of people with prospectively assessed and diagnosed PMDD, 39.1% reported current suicidal ideation during the late luteal phase. This is a reason to seek help promptly. If you’re having thoughts of suicide, call or text 988. Treatment may help reduce PMDD symptoms that contribute to suicidal thoughts, but any suicidal thinking warrants immediate attention.
Normal hormone levels don’t rule out PMDD. Current understanding is that PMDD involves an atypical sensitivity to normal hormonal fluctuations rather than a hormone imbalance. Diagnosis depends on your symptoms and their timing across the menstrual cycle, not on finding abnormal hormone levels.
Not necessarily. Because SSRIs can act quickly in PMDD, luteal-phase-only dosing during the time between ovulation and menstruation is an established option for some people. Whether this approach is right for you depends on the specific medication and your symptom pattern, so dosing decisions should be made with your prescriber.
PMDD symptoms are tied to the ovulatory cycle, so they generally stop after menopause and may be absent during pregnancy when ovulation isn’t occurring. Until then, PMDD is treatable. With an accurate diagnosis and appropriate treatment, many people can find meaningful relief from their symptoms.
Getting Support for PMDD
Living with symptoms that return on a monthly cycle can be exhausting, especially if you’ve been told they’re just a normal part of having a period. PMDD has specific diagnostic criteria and evidence-based treatment options. Finding a provider who recognizes the pattern can make it easier to get an accurate diagnosis and discuss treatment that fits your symptoms.
If you’re wondering whether PMDD could explain what you’re experiencing or you’re looking for a provider who understands cyclical mood symptoms, the Mental Health Hotline can point you toward options in your area. Call 866-903-3787 for free, confidential support, available 24/7.
Sources
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed., text revision: Premenstrual Dysphoric Disorder, 2022.
Hantsoo, Liisa and C. Neill Epperson. “Premenstrual Dysphoric Disorder: Epidemiology and Treatment.” Current Psychiatry Reports, vol. 17, no. 11, 2015.
Eisenlohr-Moul, Tory, et al. “Prevalence of Lifetime Self-Injurious Thoughts and Behaviors in a Global Sample of 599 Patients Reporting Prospectively Confirmed Diagnosis With Premenstrual Dysphoric Disorder.” BMC Psychiatry, vol. 22, 2022.
Wikman, Anna, et al. “Prevalence and Correlates of Current Suicidal Ideation in Women With Premenstrual Dysphoric Disorder.” BMC Women’s Health, vol. 22, article 35, 2022.
Reilly, Thomas J., et al. “The Prevalence of Premenstrual Dysphoric Disorder: Systematic Review and Meta-Analysis.” Journal of Affective Disorders, vol. 349, 2024.
Jespersen, Cecilie, et al. “Selective Serotonin Reuptake Inhibitors for Premenstrual Syndrome and Premenstrual Dysphoric Disorder.” Cochrane Database of Systematic Reviews, 2024.
Thys-Jacobs, Susan, et al. “Calcium Carbonate and the Premenstrual Syndrome: Effects on Premenstrual and Menstrual Symptoms.” American Journal of Obstetrics and Gynecology, vol. 179, no. 2, 1998.
Wyatt, Katrina M., et al. “Efficacy of Vitamin B-6 in the Treatment of Premenstrual Syndrome: Systematic Review.” BMJ, vol. 318, 1999.
Delray, Kyra, Glyn Lewis and Joseph F. Hayes. “Tracking Mood Symptoms Across the Menstrual Cycle in Women With Depression Using Ecological Momentary Assessment and Heart Rate Variability.” BMJ Mental Health, vol. 28, 2025, e301674.
